Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,958.00
Bid: 1,963.00
Ask: 1,965.00
Change: -36.00 (-1.81%)
Spread: 2.00 (0.102%)
Open: 2,004.00
High: 2,004.00
Low: 1,958.00
Prev. Close: 1,994.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London close: Markets nervous ahead of Jackson Hole

Wed, 29th Aug 2012 16:39

- Stocks look to Jackson Hole summit for a boost- Draghi hints at action ahead of ECB meeting- Glencore leads fallers on growing opposition to mergerGlobal stock markets were mostly trading in the red on Wednesday afternoon in spite an upwards revision to US economic growth as investors showed caution ahead of a meeting of central bankers this Friday.Investors are hoping that the Jackson Hole summit this week will see the US Federal Reserve hint at further stimulus measures like it has done in the past. However, in spite of an upwards revision to US gross domestic product (GDP) growth figures for the second quarter today - adjusted to an annual rate of 1.7% from 1.5% - US benchmarks slipped after the opening bell.Analyst Craig Erlam from Alpari said: "While [the data] in itself is unlikely to cause too much of a stir, the fact that the number has been revised higher since the last meeting is not going to work in the favour of those hoping the Fed loosen monetary policy next month."European Central Bank (ECB) President Mario Draghi is being forced to miss the Jackson Hole conference due to "a heavy workload", increasing speculation that he could be putting the finishes touches to plans for strong action ahead of an ECB meeting next week. Draghi hit back at German criticism of his bond-buying proposal today, sparking rumours that something big is on the horizon in Europe. The ECB "will always act within the limits of its mandate," Draghi said in German newspaper Die Zeit. "Yet it should be understood that fulfilling our mandate sometimes requires us to go beyond standard monetary policy tools."Alpari's Erlam said this afternoon: "I don't think there's any doubt any more than Draghi will announce their bond buying programme at the ECB press conference in September."In other news, German Chancellor Angela Merkel reiterated her opposition to the European Stability Mechanism being granted a banking licence, saying that the idea is "not compatible with the treaties". However, Italian Prime Minister Mario Monti argued that "modifications to the treaties can be asked for".FTSE 100: Glencore provides a drag on merger riskCommodities marketer and producer Glencore was leading the decline on the Footsie today, not only because it went ex-dividend today but as a result of reports that its proposed merger with mining giant Xstrata could be at risk. Xstrata shareholder Norges Bank Investment Management has raised its stake in the miner in the last few weeks, fuelling concerns that the Norwegian fund could join forces with Qatari Holdings to vote to block the merger.Miners on the whole were out of favour today as risk appetite waned. Rio Tinto, Kazakhmys, Anglo American and Vedanta Resources were registering moderate losses by the close. Copper producer Antofagasta was also lower despite beating earnings estimates in the first half as a decrease in copper prices was offset by higher levels of production. Outsourcing group Serco was higher after saying that it expects good growth in full-year organic revenues in 2012 despite a 2.1% fall in the first half. Utilities giant SSE was among the risers after Bank of America Merrill Lynch lifted its recommendation from 'neutral' to 'buy', explaining that the company's tariff increase announced last week has erased a downside risk to earnings. "The move underpins the profitability of the supply division and gives us greater confidence in the medium-term outlook for EPS and DPS progression," the broker said. Shares in Marks and Spencer were in red once again as takeover speculation continues to fade. The stock jumped on Friday after Bloomberg reported that private equity firm CVC was considering making an offer. However, analysts at Investec have said this morning that a successful bid is unlikely and the "bid spec bubble" is expected to burst. FTSE 250: RusPetro drops after swinging into the red West Siberia-focused oil and gas firm RusPetro was a heavy faller after reporting a pre-tax loss of $26.4m, compared with a profit of $0.6m in the first half of last year. Revenues, however, tripled as production ramps up. A host of second-tier stocks went ex-dividend today and were trading in the red, such as African Barrick Gold, Devro, Ferrexpo, Henderson, Hikma, Lancashire Holdings, Wood Group, Micro Focus, Rank Group and Stagecoach. FTSE 100 - RisersReed Elsevier (REL) 589.00p +1.90%Admiral Group (ADM) 1,196.00p +1.61%Babcock International Group (BAB) 914.00p +1.50%Whitbread (WTB) 2,133.00p +1.38%Compass Group (CPG) 717.00p +1.20%SSE (SSE) 1,372.00p +1.11%Aberdeen Asset Management (ADN) 277.50p +1.06%Bunzl (BNZL) 1,115.00p +1.00%Next (NXT) 3,625.00p +0.95%Sage Group (SGE) 298.70p +0.88%FTSE 100 - FallersGlencore International (GLEN) 368.50p -4.04%Rio Tinto (RIO) 2,773.50p -3.09%Weir Group (WEIR) 1,635.00p -2.79%Kazakhmys (KAZ) 617.00p -2.68%Anglo American (AAL) 1,816.00p -2.65%Vedanta Resources (VED) 889.00p -1.66%Lloyds Banking Group (LLOY) 33.49p -1.64%Xstrata (XTA) 924.10p -1.61%International Consolidated Airlines Group SA (CDI) (IAG) 142.70p -1.52%BHP Billiton (BLT) 1,904.00p -1.47%FTSE 250 - RisersCarpetright (CPR) 670.00p +4.69%Yule Catto & Co (YULC) 165.00p +4.43%Dialight (DIA) 1,140.00p +3.92%Homeserve (HSV) 220.60p +3.81%Ophir Energy (OPHR) 550.00p +3.58%Brewin Dolphin Holdings (BRW) 149.10p +3.11%SVG Capital (SVI) 279.10p +2.84%Afren (AFR) 128.20p +2.81%Cape (CIU) 192.60p +2.61%Euromoney Institutional Investor (ERM) 768.00p +2.26%FTSE 250 - FallersRuspetro (RPO) 125.50p -11.31%New World Resources A Shares (NWR) 276.00p -6.76%Bumi (BUMI) 321.30p -5.50%Ferrexpo (FXPO) 172.60p -4.11%Centamin (DI) (CEY) 76.15p -3.73%Talvivaara Mining Company (TALV) 130.00p -3.56%Lonmin (LMI) 608.00p -3.49%Rank Group (RNK) 135.70p -3.42%Henderson Group (HGG) 104.80p -2.69%Micro Focus International (MCRO) 545.00p -2.68%
More News
9 Feb 2022 09:48

LONDON BROKER RATINGS: Barclays downgrades Chemring and boohoo

LONDON BROKER RATINGS: Barclays downgrades Chemring and boohoo

Read more
3 Feb 2022 09:12

Hikma completes acquisition of Teligent's Canadian assets

Hikma completes acquisition of Teligent's Canadian assets

Read more
17 Jan 2022 09:01

TOP NEWS: Hikma Pharmaceutical acquires Teligent for USD45.8 million

TOP NEWS: Hikma Pharmaceutical acquires Teligent for USD45.8 million

Read more
17 Jan 2022 09:00

TOP NEWS: Hikma Pharmaceutical acquires Teligent for USD45.8 million

TOP NEWS: Hikma Pharmaceutical acquires Teligent for USD45.8 million

Read more
17 Jan 2022 07:49

LONDON MARKET PRE-OPEN: Unilever sees good fit in GSK Consumer Health

LONDON MARKET PRE-OPEN: Unilever sees good fit in GSK Consumer Health

Read more
17 Jan 2022 07:08

Hikma buys Teligent Canadian assets for $47.75m

(Sharecast News) - Hikma Pharmaceuticals on Monday said it had agreed to buy the Canadian assets of Teligent for $45.75m after the US firm filed for Chapter 11 bankruptcy last year.

Read more
10 Jan 2022 07:44

LONDON MARKET PRE-OPEN: Plus500 hails 2021 and mulls new share buyback

LONDON MARKET PRE-OPEN: Plus500 hails 2021 and mulls new share buyback

Read more
10 Jan 2022 07:24

Hikma launches new US injectables unit

(Sharecast News) - Hikma Pharmaceuticals on Monday said it was expanding its injectables business with the launch of a new outsourced sterile compounding business in the US.

Read more
21 Dec 2021 15:55

Arecor flags milestone payment from Hikma in first half of next year

(Sharecast News) - Biopharmaceutical company Arecor Therapeutics updated the market on its ongoing exclusive agreement with Hikma Pharmaceuticals to co-develop a new, ready-to-use injectable medicine on Tuesday.

Read more
9 Dec 2021 09:25

Hikma adds two biosimilars to portfolio with Gedeon Richter agreement

Hikma adds two biosimilars to portfolio with Gedeon Richter agreement

Read more
9 Dec 2021 08:32

Hikma strikes exclusive license agreement with Richter for denosumab

(Sharecast News) - Drugmaker Hikma Pharmaceuticals has entered into an exclusive license agreement with Gedeon Richter to commercialise the latter's denosumab products in the US.

Read more
4 Nov 2021 09:03

TOP NEWS: Hikma confirms 2021 guidance amid strong performance

TOP NEWS: Hikma confirms 2021 guidance amid strong performance

Read more
4 Nov 2021 07:58

Hikma reports solid trading in year to date

(Sharecast News) - Hikma Pharmaceuticals reiterated full-year guidance as the company reported solid trading across its business.

Read more
1 Nov 2021 13:52

Citi sees room for upside surprise on sales at Hikma Pharmaceuticals

(Sharecast News) - Analysts at Citi reiterated their 'buy' stance for shares of Hikma Pharmaceuticals ahead of the company's trading statement due out later in the same week.

Read more
28 Oct 2021 16:12

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.